Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449247) titled 'PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for Children's Myopia Prevention' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Tianjin Medical University Eye Hospital
Condition:
Pre-myopia
Intervention:
Drug: 0.01% Atropine...
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: March 30, 2026
Target Sample Size: 233
To know more, visit https://clinicaltrials.gov/study/NCT07449247
Published by...